# Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder

> **NCT01119430** · PHASE2 · TERMINATED · sponsor: **Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau** · enrollment: 50 (actual)

## Conditions studied

- Major Depression

## Interventions

- **DRUG:** DU125530
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01119430
- **Lead sponsor:** Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2004-05
- **Primary completion:** 2007-11
- **Final completion:** 2007-11
- **Target enrollment:** 50 (ACTUAL)
- **Why stopped:** interim analysis suggested no differences with whole sample
- **Last updated:** 2010-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01119430

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01119430, "Fluoxetine Versus Fluoxetine Plus DU125530 in Major Depressive Disorder". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01119430. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*